Publication | Closed Access

Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes

Metabolic SyndromeDiabetes ManagementMedicineChronic AdministrationPhysiologyDiabetesType 2Diabetes MellitusInsulin DeliveryEndocrinologyPharmacologyCell BiologyRat ModelHealth Sciences